ARCH Development Partners

ARCH Development Partners is an opaque single-family office with no publicly disclosed principals, AUM, or portfolio holdings on record.

ARCH Development Partners

ARCH Development Partners is a seed-stage venture capital fund founded to address the lack of seed venture capital in the Midwest. The firm has made 12 investments, including a Series C investment in NephRx Corporation on February 08, 2010. ARCH Development Partners has facilitated 4 portfolio exits, including the sale of SmartSignal on January 24, 2011.

linkedin.com/company/arch-development-partners

General information

Firm type

Single Family Office

Year founded

—

AUM

Undisclosed

Location

Region

—

Country

—

City

—

Corporate office

—

Does ARCH Development Partners maintain any public investment track record?

No. Altss research cannot identify a single confirmed portfolio company, fund commitment, or co-investment vehicle linked to ARCH Development Partners in the public domain. The firm appears to operate entirely outside standard institutional reporting channels.

Is ARCH Development Partners actively deploying capital?

There is no verifiable evidence of current deployment activity. Without a dated transaction, regulatory filing, or principal interview on record, the firm's operational status cannot be confirmed from public sources.

Are there any known principals or investment committee members?

No named executives, investment committee members, or beneficial owners are associated with ARCH Development Partners in commercial registries, media archives, or regulatory databases consulted by Altss.

What investment mandate does the name imply?

The term 'Development' in the firm's name may suggest a focus on real estate development, project finance, infrastructure, or early-stage venture building. However, no transaction record confirms this interpretation, and the name alone should not be treated as indicative of strategy.

How should an allocator approach ARCH Development Partners?

Any engagement must be relationship-driven. Since the firm leaves no public-facing investment signature, standard institutional due diligence—track record analysis, reference calls with GPs, regulatory background checks—is not currently feasible through open-source research.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: May 31, 2026. Continuous refresh with full update cycles at least every 30 days.